glp-1 news september 26 2025 Pipeline Update: August - Prime Therapeutics Potential New GLP-1 Side Effects

Evidence: What does the current research actually support, and how preliminary is it

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

The binding of the modified glutathione inhibitor, gamma-glutamyl-(S-benzyl)cysteinyl-D-phenylglycine, has been characterized with the phenyl group stacking against the benzyl moiety of the inhibitor and making interactions with the active-site residues Phe8 and Trp38

To confirm the C-circle results, IF was used to identify and quantify PML bodies

We defined two sets of genes, those either largely devoid of promoter bound NRF2 (Group I, green) or genes with high promoter bound NRF2 (Group II, purple) (Fig